Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 437

    Pfizer subpoenaed in US intravenous saline solution probe

    Pfizer subpoenaed in US intravenous saline solution probe

    supriya kashyap kashyap21 April 2017 11:02 AM IST
    Boston : Pfizer Inc has received grand jury subpoenas from the U.S. Justice Department in connection with an antitrust investigation focusing on drug...
    Sandoz must face wrongful death claim over heart drug - judge

    Sandoz must face wrongful death claim over heart drug - judge

    supriya kashyap kashyap21 April 2017 10:57 AM IST
    Novartis AG's Sandoz unit must face a wrongful death lawsuit accusing it of promoting a generic version of Pfizer Inc's cardiac arrhythmia drug...
    NPPA to penalise companies offering freebies on stent sales

    NPPA to penalise companies offering freebies on stent sales

    supriya kashyap kashyap21 April 2017 10:55 AM IST
    New Delhi : Drug price regulator NPPA warned coronary stent manufacturing firms of strict action if they are found giving freebies on sale of the...
    As AstraZeneca chases rivals, immuno-oncology gets complicated

    As AstraZeneca chases rivals, immuno-oncology gets complicated

    supriya kashyap kashyap21 April 2017 9:57 AM IST
    London : Three years after Pfizer's failed bid for AstraZeneca, the British drug maker aims to prove in the coming weeks that its cancer immunotherapy...
    Tevas new asthma inhaler poses first competition for GSKs Advair

    Teva's new asthma inhaler poses first competition for GSK's Advair

    Ruby Khatun Khatun21 April 2017 9:06 AM IST
    By Divya GroverTeva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to...
    Abbott Laboratories reports increased sales and profit in quarterly results

    Abbott Laboratories reports increased sales and profit in quarterly results

    Ruby Khatun Khatun20 April 2017 12:45 PM IST
    Diversified healthcare company Abbott Laboratories reported higher-than-expected quarterly sales and profit on Wednesday, driven by its $25 billion...
    Alembic Pharma gets tentative USFDA nod for antidepressant

    Alembic Pharma gets tentative USFDA nod for antidepressant

    supriya kashyap kashyap20 April 2017 12:19 PM IST
    New Delhi : Alembic Pharmaceuticals has received tentative approval from the US health regulator for vilazodone hydrochloride tablets used for...
    Glenmark gets tentative USFDA nod for anti-coagulant drug

    Glenmark gets tentative USFDA nod for anti-coagulant drug

    supriya kashyap kashyap20 April 2017 11:51 AM IST
    New Delhi : Glenmark Pharmaceuticals has received tentative nod from the US health regulator for anticoagulant medication Dabigatran Etexilate...
    Aurobindo Pharma down 4 percent on USFDA observations for Hyderabad unit

    Aurobindo Pharma down 4 percent on USFDA observations for Hyderabad unit

    supriya kashyap kashyap20 April 2017 11:40 AM IST
    New Delhi : Shares of Aurobindo Pharma fell by nearly 4 per cent after the company said that US health regulator has issued observations for its Unit...
    Piramal Enterprises Partners with IPA to Educate Stakeholders on Responsible Self-Care

    Piramal Enterprises Partners with IPA to Educate Stakeholders on Responsible Self-Care

    supriya kashyap kashyap20 April 2017 11:40 AM IST
    Mumbai : Piramal Enterprises Consumer Products business has partnered with the Indian Pharmaceutical Association (IPA), to promote responsible...
    Medtronic Signs Definitive Agreement to sell Patient Monitoring,Recovery Division to Cardinal Health for $6.1 Billion

    Medtronic Signs Definitive Agreement to sell Patient Monitoring,Recovery Division to Cardinal Health for $6.1 Billion

    supriya kashyap kashyap20 April 2017 11:40 AM IST
    Dublin : Medtronic plc announced that it has entered into a definitive agreement with Cardinal Health Inc. to sell its Patient Care, Deep Vein...
    German Merck aims to role out child formula for schistosomiasis drug

    German Merck aims to role out child formula for schistosomiasis drug

    supriya kashyap kashyap19 April 2017 11:42 AM IST
    Merck KGaA said it is developing a children's formula of its drug to treat schistosomiasis, a parasitic worm disease that infects millions of poor...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok